Search

Volatile organic compounds were collected and analyzed from a variety of indoor and outdoor air samples to test whether human-derived compounds can be readily detected in the air and if they can be associated with human occupancy or presence. Compounds were captured with thermal desorption tubes and then analyzed by gas chromatography with mass spectrometry. Isoprene, a major volatile organic compound in exhaled breath, was shown to be the best indicator of human presence. Acetone, another major breath-borne compound, was higher in unoccupied or minimally occupied areas than in human-occupied areas, indicating that its majority may be derived from exogenous sources. The association of endogenous skin-derived compounds with human occupancy was not significant. In contrast, numerous compounds that are found in foods and consumer products were detected at elevated levels in the occupied areas. Our results revealed that isoprene and many exogenous volatile organic compounds consumed by humans are emitted at levels sufficient for detection in the air, which may be indicative of human presence.

Volatile organic compounds were collected and analyzed from a variety of indoor and outdoor air samples to test whether human-derived compounds can be readily detected in the air and if they can be associated with human occupancy or presence. Compounds were captured with thermal desorption tubes and then analyzed by gas chromatography with mass spectrometry. Isoprene, a major volatile organic compound in exhaled breath, was shown to be the best indicator of human presence. Acetone, another major breath-borne compound, was higher in unoccupied or minimally occupied areas than in human-occupied areas, indicating that its majority may be derived from exogenous sources. The association of endogenous skin-derived compounds with human occupancy was not significant. In contrast, numerous compounds that are found in foods and consumer products were detected at elevated levels in the occupied areas. Our results revealed that isoprene and many exogenous volatile organic compounds consumed by humans are emitted at levels sufficient for detection in the air, which may be indicative of human presence.

In this communication, I describe the challenges in quantitative analyses for volatile organic compounds in mouse urine, which are primarily caused by the presence of the major urinary proteins, a lipocalin subfamily, that sequester volatile ligands. The analyses of volatile compounds in mouse urine have been performed since the late 1970s. However, none of them considered the binding interactions of the quantified compounds with the urinary proteins. Some volatile ligands are tightly bound to the proteins and may not be extracted completely by organic solvents. The amounts of volatile ligands measured by external standard calibration represent those of the unbound ligands in the headspace, not the total amounts in urine. Addition of internal standards displaces ligands bound to the proteins, resulting in a completely different volatile profile. Normalization of volatile compounds using relative peak area (or height) ratios may not be used in the conditions where displacement of ligands bound to the proteins occurs. Because of the unique chemical properties of mouse urine, I have not been able to find a good quantification method for the volatile compounds released from mouse urine. I hope that the identification of these issues will stimulate others to come up with novel approaches.

In this communication, I describe the challenges in quantitative analyses for volatile organic compounds in mouse urine, which are primarily caused by the presence of the major urinary proteins, a lipocalin subfamily, that sequester volatile ligands. The analyses of volatile compounds in mouse urine have been performed since the late 1970s. However, none of them considered the binding interactions of the quantified compounds with the urinary proteins. Some volatile ligands are tightly bound to the proteins and may not be extracted completely by organic solvents. The amounts of volatile ligands measured by external standard calibration represent those of the unbound ligands in the headspace, not the total amounts in urine. Addition of internal standards displaces ligands bound to the proteins, resulting in a completely different volatile profile. Normalization of volatile compounds using relative peak area (or height) ratios may not be used in the conditions where displacement of ligands bound to the proteins occurs. Because of the unique chemical properties of mouse urine, I have not been able to find a good quantification method for the volatile compounds released from mouse urine. I hope that the identification of these issues will stimulate others to come up with novel approaches.